{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T10:09:18Z","timestamp":1782122958597,"version":"3.54.5"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100018430","name":"Fondazione Istituto Europeo di Oncologia e Centro Cardiologico Monzino","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018430","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016226","name":"Accuray","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018429","name":"Istituto Europeo di Oncologia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018429","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cancertreatmentreviews.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment Reviews"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ctrv.2026.103107","type":"journal-article","created":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T17:16:00Z","timestamp":1770657360000},"page":"103107","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Proton therapy in breast cancer: bridging medical and radiation oncology"],"prefix":"10.1016","volume":"144","author":[{"given":"Daniela","family":"Alterio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Dicuonzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattia","family":"Zaffaroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7830-3149","authenticated-orcid":false,"given":"Maria Giulia","family":"Vincini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Zagami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Criscitiello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Braga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterina","family":"Milovanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Cristina","family":"Leonardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Veronesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna M.","family":"Kirby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Orecchia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Curigliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara Alicja","family":"Jereczek-Fossa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctrv.2026.103107_b0005","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of Incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ctrv.2026.103107_b0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13014-020-01501-x","article-title":"Recent advances in radiotherapy of breast cancer","volume":"15","author":"Haussmann","year":"2020","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ctrv.2026.103107_b0015","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/S0140-6736(11)61629-2","article-title":"Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials","volume":"378","author":"Early Breast Cancer Trialists\u2019 Collaborative Group (EBCTCG)","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.ctrv.2026.103107_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2022.102375","article-title":"Adjuvant and neoadjuvant breast cancer treatments: a systematic review of their effects on mortality","volume":"105","author":"Kerr","year":"2022","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.ctrv.2026.103107_b0025","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.54669","article-title":"Association of Anthracycline with Heart Failure in patients Treated for Breast Cancer or Lymphoma, 1985-2010","volume":"6","author":"Larsen","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ctrv.2026.103107_b0030","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jjcc.2019.02.001","article-title":"Cardiovascular outcome of breast cancer patients with concomitant radiotherapy and chemotherapy: a 10-year multicenter cohort study","volume":"74","author":"Kim","year":"2019","journal-title":"J Cardiol"},{"key":"10.1016\/j.ctrv.2026.103107_b0035","doi-asserted-by":"crossref","first-page":"e212","DOI":"10.1016\/j.clbc.2020.08.006","article-title":"Trastuzumab deruxtecan (DS-8201a): the latest research and advances in breast cancer","volume":"21","author":"Andrikopoulou","year":"2021","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.ctrv.2026.103107_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2022.102417","article-title":"Integrating radiation therapy with targeted treatments for breast cancer: from bench to bedside","volume":"108","author":"Meattini","year":"2022","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.ctrv.2026.103107_b0045","doi-asserted-by":"crossref","first-page":"e121","DOI":"10.1016\/S1470-2045(22)00752-5","article-title":"Metastases-directed stereotactic body radiotherapy in combination with targeted therapy or immunotherapy: systematic review and consensus recommendations by the EORTC\u2013ESTRO OligoCare consortium","volume":"24","author":"Kroeze","year":"2023","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ctrv.2026.103107_b0050","article-title":"Essential requirements for reporting radiation therapy in breast cancer clinical trials: an international multi-disciplinary consensus endorsed by the European Society for Radiotherapy and Oncology (ESTRO)","volume":"110060","author":"Kaidar-Person","year":"2023","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctrv.2026.103107_b0055","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ijrobp.2021.08.015","article-title":"Mechanisms and review of clinical evidence of variations in relative biological effectiveness in proton therapy","volume":"112","author":"Paganetti","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctrv.2026.103107_b0060","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3857\/roj.2023.00073","article-title":"Proton therapy for reducing heart and cardiac substructure doses in Indian breast cancer patients","volume":"41","author":"Nangia","year":"2023","journal-title":"Radiat Oncol J"},{"key":"10.1016\/j.ctrv.2026.103107_b0065","article-title":"Intensity modulated proton therapy for bilateral breast or chest wall and comprehensive nodal irradiation for synchronous bilateral breast cancer: initial clinical experience and dosimetric comparison","volume":"7","author":"Garda","year":"2022","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.ctrv.2026.103107_b0070","doi-asserted-by":"crossref","first-page":"E707","DOI":"10.1016\/j.ijrobp.2019.06.867","article-title":"Proton versus photon breath hold radiation for left-sided breast cancer after breast-conserving surgery: a dosimetric comparison","volume":"105","author":"Mondal","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctrv.2026.103107_b0075","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1007\/s00066-024-02263-1","article-title":"Proton therapy reduces the effective dose to immune cells in breast cancer patients","volume":"200","author":"Loap","year":"2024","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.ctrv.2026.103107_b0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-018-0757-9","article-title":"Proton irradiation orchestrates macrophage reprogramming through NF\u03baB signaling","volume":"9","author":"Genard","year":"2018","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.ctrv.2026.103107_b0085","doi-asserted-by":"crossref","first-page":"13444","DOI":"10.1038\/s41598-021-92942-1","article-title":"Impact of proton therapy on antitumor immune response","volume":"11","author":"Mirjolet","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.ctrv.2026.103107_b0090","doi-asserted-by":"crossref","first-page":"122","DOI":"10.14338\/IJPT-18-00019.1","article-title":"Advantages and limitations in the use of combination therapies with charged particle radiation therapy","volume":"5","author":"Tsuboi","year":"2018","journal-title":"Int J Part Ther"},{"key":"10.1016\/j.ctrv.2026.103107_b0095","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/ajco.13966","article-title":"Combinatorial approach of immuno-proton therapy in cancer: Rationale and potential impact","volume":"20","author":"Gaikwad","year":"2024","journal-title":"Asia Pac J Clin Oncol"},{"key":"10.1016\/j.ctrv.2026.103107_b0100","article-title":"Proton beam therapy and immunotherapy: an emerging partnership for immune activation in non-small cell lung cancer","volume":"7","author":"Jr","year":"2018","journal-title":"Transl Lung Cancer Res"},{"key":"10.1016\/j.ctrv.2026.103107_b0105","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1158\/1078-0432.CCR-17-1323","article-title":"Higher absolute lymphocyte counts predict lower mortality from early-stage triple-negative breast cancer","volume":"24","author":"Afghahi","year":"2018","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ctrv.2026.103107_b0110","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3892\/ol.2021.13143","article-title":"Baseline lymphopenia as prognostic factor in patients with metastatic breast cancer treated with palbociclib","volume":"23","author":"Emile","year":"2021","journal-title":"Oncol Lett"},{"key":"10.1016\/j.ctrv.2026.103107_b0115","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/pro6.1221","article-title":"Lymphocytopenia following adjuvant radiotherapy for breast cancer","volume":"8","author":"Takeda","year":"2024","journal-title":"Precis Radiat Oncol"},{"key":"10.1016\/j.ctrv.2026.103107_b0120","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ijrobp.2020.02.633","article-title":"Radiation-induced lymphopenia predicts poorer prognosis in patients with breast cancer: a post hoc analysis of a randomized controlled trial of postmastectomy hypofractionated radiation therapy","volume":"108","author":"Sun","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctrv.2026.103107_b0125","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.ijrobp.2020.03.012","article-title":"End-of-range radiobiological effect on rib fractures in patients receiving proton therapy for breast cancer","volume":"107","author":"Wang","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctrv.2026.103107_b0130","doi-asserted-by":"crossref","first-page":"332","DOI":"10.3390\/cells12020332","article-title":"Effect of proton therapy on tumor cell killing and immune microenvironment for hepatocellular carcinoma","volume":"12","author":"Chen","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.ctrv.2026.103107_b0135","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ijrobp.2016.02.022","article-title":"Tumor cells surviving exposure to proton or photon radiation share a common immunogenic modulation signature, rendering them more sensitive to T Cell\u2013mediated killing","volume":"95","author":"Gameiro","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctrv.2026.103107_b0140","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/stem.318","article-title":"Radiation resistance of cancer stem cells: the 4 R\u2019s of radiobiology revisited","volume":"28","author":"Pajonk","year":"2010","journal-title":"Stem Cells"},{"key":"10.1016\/j.ctrv.2026.103107_b0145","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.bbrc.2016.07.062","article-title":"Radiosensitization by PARP inhibition to proton beam irradiation incancer cells","volume":"478","author":"Hirai","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ctrv.2026.103107_b0150","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s10549-023-07150-4","article-title":"Olaparib enhances sensitization of BRCA-proficient breast cancer cells to x-rays and protons","volume":"203","author":"Park","year":"2024","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ctrv.2026.103107_b0155","doi-asserted-by":"crossref","first-page":"4943","DOI":"10.3390\/ijms20194943","article-title":"Cyclin D1 is associated with radiosensitivity of triple-negative breast cancer cells to proton beam irradiation","volume":"20","author":"Choi","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ctrv.2026.103107_b0160","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1056\/NEJMoa2202809","article-title":"Pembrolizumab plus chemotherapy in advanced triple-negative breast cancer","volume":"387","author":"Cortes","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ctrv.2026.103107_b0165","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1056\/NEJMoa2112651","article-title":"Event-free survival with pembrolizumab in early triple-negative breast cancer","volume":"386","author":"Schmid","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ctrv.2026.103107_b0170","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1080\/0284186X.2023.2238550","article-title":"Using immunotherapy to enhance the response of a C3H mammary carcinoma to proton radiation","volume":"62","author":"Nielsen","year":"2023","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ctrv.2026.103107_b0175","article-title":"Five-year outcomes of a phase 1\/2 trial of accelerated partial breast irradiation using proton therapy for women with stage 0-IIA breast cancer","volume":"9","author":"Freedman","year":"2024","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.ctrv.2026.103107_b0180","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1111\/tbj.13423","article-title":"Proton beam therapy reirradiation for breast cancer: Multi-institutional prospective PCG registry analysis","volume":"25","author":"Thorpe","year":"2019","journal-title":"Breast J"},{"key":"10.1016\/j.ctrv.2026.103107_b0185","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.ijrobp.2022.08.036","article-title":"Serial measurement of global longitudinal strain among women with breast cancer treated with proton radiation therapy: a prospective trial for 70 patients","volume":"115","author":"Hassan","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctrv.2026.103107_b0190","first-page":"4783","article-title":"Radiation-induced skin and heart toxicity in patients with breast cancer treated with adjuvant proton radiotherapy: a comparison with photon radiotherapy","volume":"13","author":"Hsieh","year":"2023","journal-title":"Am J Cancer Res"},{"key":"10.1016\/j.ctrv.2026.103107_b0195","article-title":"Proton reirradiation for locoregionally recurrent breast cancer","volume":"6","author":"LaRiviere","year":"2021","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.ctrv.2026.103107_b0200","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ijrobp.2021.05.110","article-title":"Proton therapy for breast cancer: a consensus statement from the particle therapy cooperative group (PTCOG) breast cancer subcommittee","volume":"111","author":"Mutter","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctrv.2026.103107_b0205","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2340\/1651-226X.2024.34751","article-title":"Is the risk of ischemic heart disease in women after radiotherapy for breast cancer nowadays still (linearly) associated with the mean heart dose?","volume":"63","author":"Struikmans","year":"2024","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ctrv.2026.103107_b0210","doi-asserted-by":"crossref","first-page":"59","DOI":"10.14338\/IJPT-22-00038.1","article-title":"Radiation exposure of cardiac conduction nodes during breast proton therapy","volume":"10","author":"Loap","year":"2023","journal-title":"Int J Part Ther"},{"key":"10.1016\/j.ctrv.2026.103107_b0215","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2020.00026","article-title":"Cardiotoxicity of anthracyclines","volume":"7","author":"Cardinale","year":"2020","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.ctrv.2026.103107_b0220","doi-asserted-by":"crossref","first-page":"e158","DOI":"10.1093\/oncolo\/oyab035","article-title":"Cardiotoxicity from capecitabine chemotherapy: prospective study of incidence at rest and during physical exercise","volume":"27","author":"Lestuzzi","year":"2022","journal-title":"Oncologist"},{"key":"10.1016\/j.ctrv.2026.103107_b0225","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s40959-023-00172-3","article-title":"Mechanisms of trastuzumab induced cardiotoxicity \u2013 is exercise a potential treatment?","volume":"9","author":"Eaton","year":"2023","journal-title":"Cardio-Oncology"},{"key":"10.1016\/j.ctrv.2026.103107_b0230","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.029361","article-title":"Adverse cardiovascular events associated with cyclin\u2010dependent kinase 4\/6 inhibitors in patients with metastatic breast cancer","volume":"12","author":"Fradley","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ctrv.2026.103107_b0235","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1200\/OP.23.00097","article-title":"Detecting and managing T-DXd\u2013related interstitial lung disease: the five \u201cS\u201d Rules","volume":"19","author":"Tarantino","year":"2023","journal-title":"JCO Oncol Pract"},{"key":"10.1016\/j.ctrv.2026.103107_b0240","doi-asserted-by":"crossref","unstructured":"Trastuzumab deruxtecan: risk of interstitial lung disease\/pneumonitis. Reactions Weekly 1915, 10\u201310 (2022).","DOI":"10.1007\/s40278-022-19039-9"},{"key":"10.1016\/j.ctrv.2026.103107_b0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2022.102378","article-title":"Multidisciplinary clinical guidance on trastuzumab deruxtecan (T-DXd)\u2013related interstitial lung disease\/pneumonitis\u2014Focus on proactive monitoring, diagnosis, and management","volume":"106","author":"Swain","year":"2022","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.ctrv.2026.103107_b0250","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1093\/oncolo\/oyac107","article-title":"Clinical Practices and institutional protocols on prophylaxis, monitoring, and management of selected adverse events associated with trastuzumab deruxtecan","volume":"27","author":"Bardia","year":"2022","journal-title":"Oncologist"},{"key":"10.1016\/j.ctrv.2026.103107_b0255","doi-asserted-by":"crossref","first-page":"66","DOI":"10.14338\/IJPT-21-00014","article-title":"Proton radiotherapy for patients with oligometastatic breast cancer involving the sternum","volume":"8","author":"Johnson","year":"2022","journal-title":"Int J Part Ther"},{"key":"10.1016\/j.ctrv.2026.103107_b0260","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.783327","article-title":"Clinical effectiveness of hypofractionated proton beam therapy for liver metastasis from breast cancer","volume":"11","author":"Kim","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.ctrv.2026.103107_b0265","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ijrobp.2025.01.034","article-title":"Protons versus photons postmastectomy radiation therapy effects on breast reconstruction outcomes and dosimetry analysis","volume":"122","author":"Naoum","year":"2025","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctrv.2026.103107_b0270","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1093\/asj\/sjae216","article-title":"Revision surgeries after proton vs photon postmastectomy radiation therapy in prepectoral implant\u2013based breast reconstruction","volume":"45","author":"Desai","year":"2025","journal-title":"Aesthet Surg J"},{"key":"10.1016\/j.ctrv.2026.103107_b0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-024-01979-x","article-title":"Cold and hot tumors: from molecular mechanisms to targeted therapy","volume":"9","author":"Wu","year":"2024","journal-title":"Sig Transduct Target Ther"},{"key":"10.1016\/j.ctrv.2026.103107_b0280","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-022-01102-y","article-title":"Radiotherapy combined with immunotherapy: the dawn of cancer treatment","volume":"7","author":"Zhang","year":"2022","journal-title":"Sig Transduct Target Ther"},{"key":"10.1016\/j.ctrv.2026.103107_b0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.110019","article-title":"Proton and photon radiotherapy in stage III NSCLC: Effects on hematological toxicity and adjuvant immune therapy","volume":"190","author":"Cortiula","year":"2024","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctrv.2026.103107_b0290","article-title":"High-risk non-small cell lung cancer treated with active scanning proton beam radiation therapy and immunotherapy","volume":"8","author":"Carrasquilla","year":"2023","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.ctrv.2026.103107_b0295","doi-asserted-by":"crossref","first-page":"e204","DOI":"10.1016\/j.ijrobp.2021.07.727","article-title":"Risk factors for radiation induced lymphopenia in patients with breast cancer: does radiotherapy technique matter?","volume":"111","author":"Chen","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctrv.2026.103107_b0300","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/neuonc\/noaa273","article-title":"Can proton therapy reduce radiation-related lymphopenia in glioblastoma?","volume":"23","author":"Huang","year":"2020","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ctrv.2026.103107_b0305","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.ijrobp.2022.12.030","article-title":"Proton and carbon ion radiation therapy decreased severe lymphopenia by reducing thoracic vertebra and aortic doses in non-small cell lung cancer versus intensity modulated radiation therapy","volume":"116","author":"Li","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctrv.2026.103107_b0310","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.radonc.2020.12.019","article-title":"Proton beam therapy reduces the risk of severe radiation-induced lymphopenia during chemoradiotherapy for locally advanced non-small cell lung cancer: a comparative analysis of proton versus photon therapy","volume":"156","author":"Kim","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctrv.2026.103107_b0315","first-page":"1606","article-title":"Proton beam radiotherapy combined with anti-PD1\/PDL1 immune checkpoint inhibitors for advanced hepatocellular carcinoma","volume":"12","author":"Su","year":"2022","journal-title":"Am J Cancer Res"}],"container-title":["Cancer Treatment Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305737226000216?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305737226000216?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T07:35:45Z","timestamp":1773041745000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0305737226000216"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":63,"alternative-id":["S0305737226000216"],"URL":"https:\/\/doi.org\/10.1016\/j.ctrv.2026.103107","relation":{},"ISSN":["0305-7372"],"issn-type":[{"value":"0305-7372","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Proton therapy in breast cancer: bridging medical and radiation oncology","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctrv.2026.103107","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103107"}}